Science/ Research News

Avila Therapeutics™, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug. In the paper titled “Selective Irreversible ... read more

Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K-delta) inhibitors for the treatment of cancer and inflammatory diseases, today announced the upcoming presentation of clinical and preclinical results supporting the clinical benefit of CAL-101, an oral, PI3K-delta ... read more

Zalicus Inc. (NASDAQ: ZLCS) announced today that preclinical data on its discovery of novel A2A agonist oncology programs for the treatment of multiple myeloma and other B-cell malignancies will be highlighted at the 52nd Annual Meeting of the American Society of Hematology in Orlando, FL on ... read more

Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new ... read more

An interview with Dr. Sam Stupp, founder and scientific advisor to Nanotope, Inc., an Arrowhead (NASDAQ: ARWR) portfolio company, was broadcast by the BBC World Service on November 28, 2010. In the interview, Dr. Stupp describes and discusses the regenerative medicine platform being developed by Nanotope, ... read more

Nanostart (OTCQX:NASRY)-holding Nanosys has entered into a distribution agreement with multi-billion dollar concern Sigma-Aldrich (Nasdaq: SIAL). Under the agreement, Sigma-Aldrich, through its Aldrich Material Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new ... read more

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme® (ferumoxytol) Injection for intravenous (IV) use. The updated product label, also called a package insert, includes, ... read more

Targeted Genetics Corporation, (Pink Sheets: TGEN), or the Company, today announced that the Company’s next Annual Meeting of shareholders will be held on January 27, 2011, at 11:00 a.m. local time in Seattle, Washington at a location to be determined. The Company’s Board of Directors has ... read more

BioTime, Inc. (NYSE Amex: BTX) today announced an agreement with the California Institute for Regenerative Medicine (CIRM) to make five clinical-grade human embryonic stem (hES) cell lines available to California-based researchers. CIRM is the stem cell agency created when California voters supported a $3 billion funding ... read more

Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California). Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery services ... read more

Biomedical Market Newsletter, Inc. (http://www.biomedical-market-news.com), a veteran medical industry information provider, has announced its 20th year in business.  Biomedical Market Newsletter assists medical industry organizations, conference organizers, and related companies in reaching out to medical ... read more

The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD) today announced that Covidien, a leading global provider of healthcare products, has licensed an innovative drug-delivery platform technology invented by UBC researcher, Pieter Cullis. This transaction represents the first successful licensing ... read more

FIRST® (For Inspiration and Recognition of Science and Technology), an organization founded by inventor Dean Kamen to inspire young people’s interest and participation in science and technology, today announced NASA has awarded a five-year agreement to FIRST to provide support ... read more

The Biotechnology Industry Organization (BIO) today announced a specialized workshop on advancements in synthetic biology that will highlight a new effort called the BIOFAB: International Open Facility Advancing Biotechnology, which aims to produce thousands of free, standardized DNA parts. ... read more

SeraCare Life Sciences, Inc. (NASDAQ: SRLS) will release its fourth quarter and fiscal year 2010 financial results before U.S. financial markets open on Wednesday, December 1, 2010. SeraCare executives will host a conference call at 8:30 A.M. Eastern Time on the same day to review 2010 ... read more

Yves A. DeClerck, MD, professor of Pediatrics, Biochemistry and Molecular Biology at the Keck School of Medicine of the University of Southern California, has been inducted as the inaugural holder of the Richard Call Family Endowed Chair in Pediatric Research Innovation. Dr. Yves DeClerck ... read more

Exelixis, Inc. (Nasdaq:EXEL) announced today that it will host its Annual R&D Day on Thursday, December 2, 2010 from 10:00 a.m. EST / 7:00 a.m. PST until 2:30 p.m. EST / 11:30 a.m. PST. Exelixis management will outline the development priorities for XL184, discuss the company's ... read more

The U.S. Court of Appeals for the Second Circuit today ruled that a Vermont law restricting the commercial use of information relating to physician prescribing patterns is unconstitutional. Judge John G. Koeltl wrote the majority opinion overturning an April 2009 U.S. District Court decision, concluding the ... read more

Aeris Therapeutics (www.aerist.com) received US Patent 7,819,908, entitled “Compositions and Methods for Reducing Lung Volume.” The patent includes broad claims related to the application of energy via a catheter as a method for non-surgical lung volume reduction. The patent enhances the company’s “best in class” ... read more

The Conference Forum announced that on January 14th in San Francisco, the three most important strategies to strengthen your drug development plan come together in a one day meeting with an outstanding speaking faculty. Your strategy behind Biomarkers, Comparative Effectiveness Research and Outsourcing are central to ... read more